Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar

Calendario económico
Señales Comerciales
WebTerminal

Pulse / para buscar: @user, $symbol, ... Buscar

English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe

MGX

#3462

Metagenomi Therapeutics, Inc. Common Stock

1.5200

-1.83%

Sector:

Básica:

Profit Currency:

Rango diario

1.5200

1.5200

Rango anual

1.4100

1.5850

Cambio diario

-1.83%

Monthly Change

+5.56%

6 month change

+5.56%

Cambio anual

+5.56%

Cierres anteriores

1.5484

Open

1.5200

Bid

Ask

Low

1.5200

High

1.5200

Volumen

4

Markets
Acciones
Atención Sanitaria
MGX

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Income statement Balance sheet Cash flow

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 11.51 M9.61 M4.13 M8.51 M8.66 M 30.91 M Gross profit 11.51 M9.61 M4.13 M8.51 M8.66 M 30.91 M Operating expenses 33.9 M30.24 M31.95 M29.5 M31.5 M 123.18 M Selling/general/admin expenses 7.64 M7.07 M6.8 M6.99 M6.21 M 27.09 M Research & development 26.26 M23.16 M25.14 M22.51 M25.28 M 96.1 M Operating income -22.38 M-20.62 M-27.82 M-20.99 M-22.84 M -92.27 M Non-Operating Income, Total 1.5 M-3.98 M2.88 M1.12 M2.21 M 2.23 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 1.56 M-3.93 M2.89 M1.19 M2.21 M 2.36 M Unusual income/expense -57 K-49 K-8 000-70 K-2 000 -129 K Pretax income -20.88 M-24.61 M-24.94 M-19.86 M-20.63 M -90.04 M Equity in earnings ————— — Taxes -2.11 M-1.21 M98 K44 K-50 K -1.12 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -18.77 M-23.4 M-25.04 M-19.91 M-20.39 M -88.74 M Discontinued operations ————— — Net income -18.77 M-23.4 M-25.04 M-19.91 M-20.39 M -88.74 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 18.77 M23.4 M25.04 M19.91 M20.39 M 88.74 M Basic earnings per share (Basic EPS) -0.25-0.37-0.68-0.53-0.54 -2.12 Diluted earnings per share (Diluted EPS) -0.25-0.37-0.68-0.53-0.54 -2.12 Average basic shares outstanding 31.6 M33.03 M37.02 M37.09 M37.18 M 144.31 M Diluted shares outstanding 31.6 M33.03 M37.02 M37.09 M37.18 M 144.31 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) -262 K112 K351 K517 K619 K 1.6 M

Noticias

anteayer, 22:30

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Markets

Acciones
Divisas
Criptomonedas
Metales
Mercancías

Charts & Ideas

Ideas comerciales
Ideas ilustrativas
Gráfico

MQL5 Community

Market
Señales
Foro
Artículos
CodeBase

Noticias

Acciones
Divisas
Criptomonedas
Metales
Mercancías

Corredores

Todos los brókeres
Fórex
Acciones
Metales

Economic Calendar

Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal

Copyright 2000-2026, MetaQuotes Ltd